Key takeaways
Farxiga (dapagliflozin) and Jardiance (empagliflozin) are both SGLT2 inhibitors used to manage Type 2 diabetes. While both medications work similarly, there are some differences between them. Unlike Jardiance, Farxiga is safe for use in children ages 10 years and older. Farxiga is not recommended during the second and third trimesters of pregnancy, and Jardiance must be paused before certain surgeries. Common side effects of Jardiance include high cholesterol, which was not reported with Farxiga. Serious side effects can happen with both medication; however only Jardiance has a risk of leg and foot amputations.
